SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M Elbaz, N Yanay, S Laban, M Rabie, S Mitrani-Rosenbaum, Y Nevo, Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A, Cell Death and Disease, 2015, 6, 3, e1690

    CrossRef

  2. 2
    Amanda M Murphy, Alison L Wong, Michael Bezuhly, Modulation of angiotensin II signaling in the prevention of fibrosis, Fibrogenesis & Tissue Repair, 2015, 8, 1

    CrossRef

  3. 3
    Matthew N. Meriggioli, Ronenn Roubenoff, Prospect for Pharmacological Therapies to Treat Skeletal Muscle Dysfunction, Calcified Tissue International, 2015, 96, 3, 234

    CrossRef

  4. 4
    Claudio Cabello-Verrugio, María Gabriela Morales, Juan Carlos Rivera, Daniel Cabrera, Felipe Simon, Renin-Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle, Medicinal Research Reviews, 2015, 35, 3
  5. 5
    Harry Dietz, A healthy tension in translational research, Journal of Clinical Investigation, 2014, 124, 4, 1425

    CrossRef

  6. 6
    Zandra Körner, Cibely C. Fontes-Oliveira, Johan Holmberg, Virginie Carmignac, Madeleine Durbeej, Bortezomib Partially Improves Laminin α2 Chain–Deficient Muscular Dystrophy, The American Journal of Pathology, 2014, 184, 5, 1518

    CrossRef

  7. 7
    Johan Holmberg, Azra Alajbegovic, Kinga Izabela Gawlik, Linda Elowsson, Madeleine Durbeej, Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  8. 8
    M. J. Acuna, P. Pessina, H. Olguin, D. Cabrera, C. P. Vio, M. Bader, P. Munoz-Canoves, R. A. Santos, C. Cabello-Verrugio, E. Brandan, Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-  signalling, Human Molecular Genetics, 2014, 23, 5, 1237

    CrossRef

  9. 9
    Yacine Kharraz, Joana Guerra, Patrizia Pessina, Antonio L. Serrano, Pura Muñoz-Cánoves, Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy, BioMed Research International, 2014, 2014, 1

    CrossRef

  10. 10
    Jessica J. Miciak, Leigh C. Warsing, Maria E. Tibbs, Jeffrey R. JASPER, Sarah B. Jampel, Fady I. Malik, Clarke Tankersley, Kathryn R. Wagner, Fast skeletal muscle troponin activator in the dy2J muscular dystrophy model, Muscle & Nerve, 2013, 48, 2
  11. 11
    Tadashi Yoshida, A. Michael Tabony, Sarah Galvez, William E. Mitch, Yusuke Higashi, Sergiy Sukhanov, Patrice Delafontaine, Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: Potential therapeutic targets for cardiac cachexia, The International Journal of Biochemistry & Cell Biology, 2013, 45, 10, 2322

    CrossRef

  12. 12
    J. Yamauchi, A. Kumar, L. Duarte, T. Mehuron, M. Girgenrath, Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A, Human Molecular Genetics, 2013, 22, 21, 4306

    CrossRef

  13. 13
    Sarina Meinen, Shuo Lin, Markus A Ruegg, Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A), Skeletal Muscle, 2012, 2, 1, 18

    CrossRef

  14. 14
    Elizabeth M. MacDonald, Ronald D. Cohn, TGFβ signaling, Current Opinion in Rheumatology, 2012, 24, 6, 628

    CrossRef